A California-based biotech company is stealing the show during Wednesday’s premarket after it was announced that the FDA approved Udenyca Onbody, a device used to deliver...

To read the full story on AllPennyStocks.com, click here.

Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Coherus BioSciences Charts.
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Coherus BioSciences Charts.